Krainer is a Uruguayan-American Biochemist and Molecular Geneticist.
Krainer holds the St.
Giles Foundation Professorship at Cold Spring Harbor Laboratory.
He is a 2019 Breakthrough Prize in Life Sciences for his contributions to the understanding of the RNA gene-splicing process and, in collaboration with fellow Prize Laureate Dr.
Frank Bennet of Ionis Pharmaceuticals, the development of medical interventions that target the gene-splicing process, including Spinraza, which is the first treatment for the genetic disorder Spinal Muscular Atrophy.